Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,105 USD | +2,31% |
|
+2,40% | -62,51% |
Attività
Numero di dipendenti: 74
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Neuroscience and Immuno-oncology Drugs
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +268,00% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Vimal Mehta
FOU | Founder | 63 | 29/03/17 |
Director of Finance/CFO | 66 | 01/10/17 | |
Frank Yocca
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/06/17 |
Vincent O'Neill
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/07/17 |
Brennan Doyle
IRC | Investor Relations Contact | - | - |
Chetan Lathia
LAW | General Counsel | - | - |
Matthew Wiley
PRN | Corporate Officer/Principal | 52 | 19/01/22 |
Javier Rodriguez
LAW | General Counsel | 52 | 23/02/21 |
55 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 01/07/22 |
Peter Mueller
CHM | Chairman | 68 | 01/04/17 |
Sandeep Laumas
BRD | Director/Board Member | 56 | 01/09/17 |
Vimal Mehta
FOU | Founder | 63 | 29/03/17 |
55 | - | ||
Michal Votruba
BRD | Director/Board Member | 58 | 07/03/19 |
June Bray
BRD | Director/Board Member | 70 | 01/03/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 37 530 821 | 29 357 654 ( 78,22 %) | 0 | 78,22 % |
Coordinate società
BioXcel Therapeutics, Inc.
555 Long Wharf Drive 12th floor
06511, New Haven
+475 238 6837
http://www.bioxceltherapeutics.com![Indirizzo BioXcel Therapeutics, Inc.(BTAI)](https://cdn.zonebourse.com/static/address/41713826.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-62,51% | 40,53 Mln | |
+19,55% | 125 Mrd | |
+20,61% | 114 Mrd | |
+25,30% | 26,73 Mrd | |
-23,93% | 19,43 Mrd | |
-18,10% | 16,22 Mrd | |
-18,84% | 15,33 Mrd | |
+9,29% | 14,42 Mrd | |
-48,41% | 14,33 Mrd | |
+55,91% | 14,2 Mrd |
- Borsa valori
- Azioni
- Azione BTAI
- Società BioXcel Therapeutics, Inc.